Laura has extensive experience in all aspects of clinical outcome assessment (COA) instrument development and modification and provides strategic insight in the design of study methodologies, navigation of the regulatory landscape and the identification of solutions to challenges in the development and execution of COA strategies. Laura has worked with a large number of different clients within the pharmaceutical industry and has experience of working across a range of disease areas, including: dermatology, endocrinology, rheumatology, rare diseases and respiratory disease and has a particular interest and experience in women’s health. Laura has been involved in multiple regulatory submissions and has published research in a number of peer reviewed journals. Prior to joining Adelphi Values, Laura worked at University College London and has an MSc in Clinical and Health Psychology from the University of Manchester.